Gary S Jacob's Net Worth

-$710 Thousand

Estimate Recalculated Sep 9, 2024 12:35AM EST

Who is Gary S Jacob

Gary S Jacob does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Synergy Pharmaceuticals, Inc., Virpax Pharmaceuticals, Inc., Hepion Pharmaceuticals, Inc., TrovaGene Inc., OKYO Pharma Ltd, and CALLISTO PHARMACEUTICALS INC.

SEC CIK

Gary S Jacob's CIK is 0001266802

Past Insider Trading and Trends

2013 was Gary S Jacob's most active year for acquiring shares with 16 total transactions. Gary S Jacob's most active month to acquire stocks was the month of December. 2013 was Gary S Jacob's most active year for disposing of shares, totalling 8 transactions. Gary S Jacob's most active month to dispose stocks was the month of December. 2018 saw Gary S Jacob paying a total of $8,877,480.50 for 1,504,590 shares, this is the most they've acquired in one year. In 2017 Gary S Jacob cashed out on 909,287 shares for a total of $0.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Synergy Pharmaceuticals, Inc.

Executive Chairman

Updated Jun 18, 2018


Form 4	-3.82%	-282.18K	$0.50	$237.48K	Jun 18, 2018	7.11M	Options	—	Jun 15
Form 4	15.73%	950.00K	—	—	Jan 09, 2018	6.99M	Grant	—	Jan 05
Form 4	—	—	—	—	Jun 30, 2017	11.18M	Acq/Dis	—	Jun 28
Form 4	1.43%	5.68K	$3.52	$19.97K	May 30, 2017	402.68K	Purchase	—	May 26
Form 4	19.65%	970.00K	—	—	Jun 27, 2016	5.91M	Grant	—	Jun 24
Form 4	11.27%	500.00K	—	—	Sep 30, 2015	4.94M	Grant	—	Sep 29
Form 4	7.25%	300.00K	—	—	Jul 28, 2015	4.44M	Grant	—	Jul 24
Form 4	—	—	$5.61	$353.23K	Jul 01, 2015	4.53M	Options	—	Jul 01
Form 4	31.27%	1.00M	—	—	Dec 09, 2014	4.20M	Grant	—	Dec 06
Form 4	10.35%	300.00K	—	—	Jun 12, 2014	3.20M	Grant	—	Jun 10
Form 4	1.20%	4.00K	$4.18	$16.72K	May 28, 2014	338.03K	Purchase	—	May 27
Form 4/A	3.19%	100.00K	—	—	Jul 17, 2013	3.24M	Grant	—	Jul 12
Form 4	3.57%	100.00K	—	—	Jul 16, 2013	2.90M	Grant	—	Jul 12
Form 4/A	2.04%	366.50K	—	—	Jan 22, 2013	18.37M	Grant	—	Jan 17
Form 4	1.74%	313.52K	—	—	Jan 22, 2013	18.37M	Grant	—	Jan 17
Form 4	27.30%	600.00K	—	—	Dec 13, 2012	2.80M	Grant	—	Dec 11
Form 4	11.30%	223.18K	—	—	Aug 09, 2012	2.20M	Grant	—	Aug 07
Form 4	43.64%	600.00K	—	—	Jan 03, 2012	1.97M	Grant	—	Dec 29
Form 4	—	50.41K	$8.00	$403.30K	Dec 08, 2011	50.41K	Purchase	—	Dec 06
Form 3	—	—	—	—	Aug 03, 2011	374.94K	—	—	—

Showing 20 results

Virpax Pharmaceuticals, Inc.

Investor

Updated Jan 05, 2022

View Quote Details


Form 4	—	12.09K	—	—	Jan 05, 2022	12.09K	Grant	—	Jan 01
Form 4	—	13.18K	—	—	Apr 09, 2021	13.18K	Grant	—	Apr 07
Form 4	—	3.50K	$6.79	$23.76K	Feb 19, 2021	3.50K	Purchase	—	Feb 17
Form 3	—	—	—	—	Feb 16, 2021	—	—	—	—

Showing 4 results

Hepion Pharmaceuticals, Inc.

CEO and President

Updated Feb 21, 2024

View Quote Details


Form 4	496.50%	85.00K	—	—	Feb 21, 2024	102.12K	Grant	—	Feb 19
Form 4	269.44%	250.00K	—	—	May 20, 2021	342.79K	Grant	—	May 18
Form 4	20,338.98%	12.00K	$1.66	$19.92K	Dec 01, 2020	12.06K	Purchase	—	Dec 01
Form 4	47.78%	30.00K	—	—	Aug 21, 2020	92.79K	Grant	—	Aug 19
Form 4	2,198.61%	60.00K	—	—	Apr 07, 2020	62.73K	Grant	—	Apr 03
Form 4	55.14%	970.00	—	—	Jul 25, 2019	2.73K	Grant	—	Jul 24
Form 4	—	8.64K	$1,000.00	$8.64M	Jul 03, 2018	8.64K	Purchase	—	Jul 03
Form 4	6.84%	65.00K	—	—	Jul 20, 2016	1.02M	Grant	—	Jul 19
Form 4	79.25%	420.00K	—	—	Dec 04, 2014	950.00K	Grant	—	Dec 03
Form 4	130.43%	300.00K	—	—	Mar 20, 2014	530.00K	Grant	—	Mar 19
Form 4	—	32.94K	—	—	Feb 20, 2014	32.94K	Acq/Dis	—	Feb 18
Form 4	666.67%	200.00K	—	—	Jan 28, 2014	230.00K	Grant	—	Jan 24
Form 3	—	—	—	—	Oct 07, 2013	—	—	—	—

Showing 13 results

TrovaGene Inc.

Investor

Updated Jun 15, 2021

View Quote Details


Form 4	14.23%	75.83K	—	—	Jun 15, 2021	608.85K	Acquisition	—	Jun 10
Form 4	12.12%	2.37K	$10.42	$24.69K	Mar 23, 2021	21.92K	Purchase	—	Mar 23
Form 4	61.08%	28.86K	—	—	Jun 19, 2020	76.11K	Grant	—	Jun 17
Form 4	845.00%	17.48K	$1.43	$25.00K	May 18, 2020	19.55K	Purchase	—	May 14
Form 4	1,340.55%	44.73K	—	—	Jun 24, 2019	48.07K	Grant	—	Jun 20
Form 4	28.03%	54.32K	—	—	Jan 25, 2018	248.10K	Grant	—	Jan 23
Form 4	—	—	—	—	Jan 04, 2018	148.95K	Options	—	Jan 02
Form 4	24.48%	38.11K	—	—	Oct 05, 2017	193.78K	Grant	—	Oct 04
Form 4	—	—	—	—	Sep 06, 2017	148.95K	Options	—	Sep 02
Form 4/A	—	25.95K	—	—	Jan 05, 2017	25.95K	Grant	—	Jan 02
Form 4	—	16.67K	—	—	Jan 04, 2017	16.67K	Grant	—	Jan 02
Form 4	11.46%	16.00K	—	—	Jan 06, 2016	155.67K	Grant	—	Jan 04
Form 4	12.94%	16.00K	—	—	Mar 19, 2015	139.67K	Grant	—	Mar 17
Form 4	14.51%	15.67K	—	—	Dec 15, 2014	123.67K	Grant	—	Dec 11
Form 4	24.19%	21.04K	—	—	Feb 26, 2014	108.01K	Grant	—	Feb 25
Form 4	18.33%	13.47K	—	—	Feb 21, 2013	86.97K	Grant	—	Feb 14
Form 4	8.89%	36.00K	—	—	Feb 15, 2012	441.00K	Grant	—	Jan 26
Form 3	—	—	—	—	Jan 24, 2012	738.00K	—	—	—

Showing 18 results

OKYO Pharma Ltd

Chief Executive Officer

Updated May 19, 2022

View Quote Details


Form 4	—	12.50K	$4.00	$50.00K	May 19, 2022	12.50K	Purchase	—	May 19
Form 3	—	—	—	—	May 16, 2022	—	—	—	—

Showing 2 results

CALLISTO PHARMACEUTICALS INC

Chief Executive Officer

Updated Jan 22, 2013


Form 4	-100.00%	-2.04M	—	—	Jan 22, 2013	—	Disposition	—	Jan 17
Form 4	26.00%	390.00K	—	—	Jan 27, 2010	1.89M	Grant	—	Jan 26
Form 4	9.26%	12.50K	$0.49	$6.13K	Oct 25, 2007	147.43K	Acquisition	—	Oct 23
Form 4	17.65%	225.00K	—	—	Feb 20, 2007	1.50M	Grant	—	Feb 16
Form 4	3.85%	5.00K	$0.84	$4.20K	Aug 22, 2006	134.75K	Purchase	—	Aug 21
Form 4	13.33%	150.00K	—	—	Mar 29, 2006	1.28M	Grant	—	Mar 17
Form 4	45.16%	350.00K	—	—	Jul 22, 2005	1.13M	Grant	—	Jul 06
Form 4	4.01%	5.00K	$1.00	$5.00K	Jun 17, 2005	129.75K	Purchase	—	Jun 16
Form 4	15.19%	16.45K	$1.52	$25.00K	Mar 11, 2005	124.75K	Purchase	—	Mar 09
Form 3	—	—	—	—	Oct 22, 2004	108.30K	—	—	—

Showing 10 results